# Tekes Venture Capital

> Tekes Venture Capital is a VC fund backing Genetics and Hospital. See 2 investments, round sizes, portfolio and contact details. Updated Oct 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Jan 2019
- Lead investor: 0%
- Last updated: Oct 2026

Tekes Venture Capital is a VC fund focused on Genetics and Hospital. Tekes Venture Capital invests in companies in their early stages of development. Its purpose is to develop Finland's venture capital market.

## Contacts

5 contacts available for Tekes Venture Capital. Shizune tracks 1 team members at Tekes Venture Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/tekes-venture-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Genetics | 1 | 50% |
| Hospital | 1 | 50% |
| Analytics | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Finland | 1 | 50% |
| United States | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Esko Raunio | Managing Director | 0 | https://shizune.co/investors/profile/esko-raunio |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| 720 Degrees | 720° is a cloud based analytics solution for indoor environmental quality monitoring. They believe that health and satisfaction at work is everyone’s prerogative. Their passion is to improve people’s lives and allow organisations and building owners to offer the best working environments achievable. | $3.3M | Seed | Jan 31, 2019 | https://720.io/en/ |
| Blueprint Genetics | Blueprint Genetics provides genetic diagnostics of rare diseases based on Next-Generation Sequencing (NGS).The professional genetic tests are targeted for hospitals and research groups. Blueprint Genetics aims to disrupt the market by decreasing the price level of genetic diagnostics significantly while increasing quality and adding clinicalinsight to the results statements.The tests are based on a novel NGS method called OS-Seq:tm: that was developed in the Stanford University.The product roadmap of the company covers a long list of diagnostics for different hereditary diseases. The currently available products cover relevant rare hereditary cardiovascular diseases, such as cardiomyopathies, arrhythmias and aorta diseases.The company is based in Helsinki, Finland and has an office also in Los Angeles, CA. | $3.9M | Venture - Series Unknown | Sep 01, 2014 | http://www.blueprintgenetics.com |

2 of 2 investments shown.

## Co-investors
- [Business Finland](https://shizune.co/investors/profile/business-finland) — VC Fund, 1 deal together
- [FiBAN - Finnish Business Angels Network](https://shizune.co/investors/profile/fiban-finnish-business-angels-network) — VC Fund, 1 deal together
- [Horizon 2020](https://shizune.co/investors/profile/horizon-2020) — VC Fund, 1 deal together
- [Inventure](https://shizune.co/investors/profile/inventure-oy) — VC Fund, 1 deal together
- [J&T Ventures](https://shizune.co/investors/profile/j-t-ventures) — VC Fund, 1 deal together
- [Pi Labs](https://shizune.co/investors/profile/pi-labs-2) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [SOSV SF & NY (Fka IndieBio)](https://shizune.co/investors/profile/synbio-axlr8r) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund

### Similar stage
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund
- [Lifeline Ventures](https://shizune.co/investors/profile/lifeline-ventures) — VC Fund
- [Tesi](https://shizune.co/investors/profile/tesi) — VC Fund

## Featured in investor lists
- [Biotechnology VC Funds in Finland](https://shizune.co/investors/biotechnology-vc-funds-finland)
- [Biotech VC Funds in Finland](https://shizune.co/investors/biotech-vc-funds-finland)
- [Biotechnology Investors in Finland](https://shizune.co/investors/biotechnology-investors-finland)

## FAQ

### What does Tekes Venture Capital invest in?

Tekes Venture Capital invests primarily in Genetics, Hospital and Analytics startups, most often at Seed and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Tekes Venture Capital?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Tekes Venture Capital?

The team at Tekes Venture Capital includes Esko Raunio (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co